SCHEDULE OF INFORMATION ABOUT THE WARRANTS OUTSTANDING (Details) - $ / shares |
12 Months Ended | |
---|---|---|
Dec. 31, 2023 |
Dec. 30, 2023 |
|
Subsequent Events [Abstract] | ||
Original number of warrants issued | 1,250 | |
Exercise price per common share | $ 8.00 | |
Number of warrants exercisable | 1,250 | |
Number of warrants became exercisable | 1,250 | |
Number of warrants exercised | ||
Number of warrants terminated / canceled / expired | 1,250 |
X | ||||||||||
- Definition Share based compensation arrangement by share based payment award options became exercisable number. No definition available.
|
X | ||||||||||
- Definition Exercise price per share or per unit of warrants or rights outstanding. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition Number of options outstanding, including both vested and non-vested options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Number of share options (or share units) exercised during the current period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- References No definition available.
|